Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Pfizer, Eli Lilly, Other Pharma Stocks Fall as Trump Targets Lower Drug Prices
07:10am, Monday, 12'th May 2025
Trump said he would lower the cost of medicines for Americans by between 30% and 80%.
Wondering if Pfizer's 7.6% Dividend Yield Is Sustainable? Here's What You Need to Know.
04:51am, Monday, 12'th May 2025
Income investors have liked Pfizer (PFE -1.13%) for years. However, the big drugmaker's exceptionally juicy dividend these days has made its stock even more attractive.
3 Magnificent S&P 500 Dividend Stocks Down 30% to Buy and Hold Forever
05:39am, Saturday, 10'th May 2025
There are a few things that Ford Motor Company (F 1.41%), Target (TGT -0.65%), and Pfizer (PFE -1.13%), have in common. They are all components of the prestigious S&P 500.
Pfizer (NYSE:PFE) Hasn't Been This Cheap in 13 Years. Time to Buy?
11:21am, Friday, 09'th May 2025
Pfizer (NYSE:PFE) is one of the world's largest pharmaceutical companies, but at $22.59 per share as of this writing, the stock trades at its lowest levels in 13 years.
Pfizer (PFE) Just Overtook the 20-Day Moving Average
10:55am, Friday, 09'th May 2025
From a technical perspective, Pfizer (PFE) is looking like an interesting pick, as it just reached a key level of support. PFE recently overtook the 20-day moving average, and this suggests a short-te
5 Low Price-to-Sales Stocks That Deserve a Place in Your Portfolio
09:15am, Friday, 09'th May 2025
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like PCB, GIII, ROCK, PFE and PAM hold promise.
Hard To Imagine Retirement Income Portfolio Without These 2 Picks
09:15am, Friday, 09'th May 2025
Typically, investors put a focus on high-yield securities if the goal is to live off from portfolio income streams. These high-yielding securities come from BDC, REIT, MLP, CEF and other value-oriente
Pressure is still on the pharma sector, says Mizuho's Jared Holz
07:23pm, Thursday, 08'th May 2025
Jared Holz, Mizuho, joins 'Fast Money' to talk headwinds to the pharma sector.
Can Pfizer (PFE) Climb 25.14% to Reach the Level Wall Street Analysts Expect?
11:02am, Thursday, 08'th May 2025
The mean of analysts' price targets for Pfizer (PFE) points to a 25.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts i
Dividend Harvesting Portfolio Week 218: $21,800 Allocated, $2,195.04 In Projected Dividends
09:00am, Thursday, 08'th May 2025
Earnings season saw strong reports from Microsoft, Apple, Meta, and Amazon, boosting the S&P 500 by 2.75% and the Nasdaq by 2.82%. The Dividend Harvesting Portfolio gained 1.98% this week, with a tota
Want $3,100 in Annual Dividends? Invest $18,000 in Each of These 3 Stocks
05:45am, Thursday, 08'th May 2025
The average stock on the S&P 500 yields just 1.4%. If you invested $54,000 into stocks averaging that kind of a yield, you'd collect just $756 in annual dividend income.
3 Ultra-High Yield Dividend Stocks to Buy This May
03:40pm, Wednesday, 07'th May 2025
These three companies have a dividend yield higher than 5%. Not only are these solid business, but they have raised dividends for many years and offer capital appreciation.
New vaccine chief rocks pharmaceutical stocks
11:13am, Wednesday, 07'th May 2025
CNBC's Angelica Peebles joins 'Squawk on the Street' to discuss how the biotech and pharma industry is reacting to a new FDA chief of vaccines appointed by President Trump.
Build A 12%+ Yield On Cost By 2035 With May's Top 10 High-Yield Picks
06:00pm, Tuesday, 06'th May 2025
In this article, I present 10 attractive high-yield investment options for this month of May 2025, which not only offer dividend income but also potential for dividend growth. The selection process in
Pfizer Has Unreasonable Whiff Of The Marlboro Man
11:47am, Tuesday, 06'th May 2025
What makes Pfizer and Altria alike? They have trouble keeping their customers. Altria's dividend yield is 7%, even as it trades at 11 times estimated earnings over the next 12 months – a 40% premium
